Breaking News

BioCina Expands into Full-service mRNA CDMO

Takes full control of Pfizer manufacturing facility in Adelaide, Australia.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BioCina, a contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of microbial-based therapeutics and mRNA vaccines announced the full and final transition from Hospira Adelaide Pty. Ltd., an affiliate of Pfizer Inc., of its biologics manufacturing facility, colleagues and operations in Adelaide, Australia. This completes BioCina’s August 2020 acquisition of the facility.   Added capabilities for BioCina now include manufacturi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters